Abstract
In the past several decades, neurotransplantation has been investigated for the study of development of the normal nervous system and possible functional restoration and repair of diseased and damaged nervous tissue (1,2). In patients with Parkinson’s disease, transplantation of dopamine-producing human and pig fetal tissues has resulted in varying degrees of clinical improvements, which correlated with graft survival and anatomical integration of the grafted fetal cells into the host brain (3–5), albeit, the control of dopamine release remains an issue (5). In animal studies, implantation of neural stem cells and partially differentiated embryonic stem cells into lesioned brain and spinal cord resulted in more rapid behavioral improvement in experimental models of spinal cord injury, stroke, and neurotrauma (6–11). Although implantation of embryonic stem cells can be a promising method of cell therapy, obtaining fetal and embryonic tissues has presented major logistical, ethical, and immunological barriers (12,13). Thus, autologous cells from the bone marrow, marrow stromal cells, can be an attractive alternative source of tissue for grafting and treatment of neurological diseases (11).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bjorklund, A. (1991) Neural transplantation—an experimental tool with clinical possibilities. TINS 14, 319–322.
Bjorklund, A. (1993) Better cells for brain repair. Science 276, 66–71.
Kordower, J. H., Freeman, T. B., Snow, B. J., Vingerhoets, F. J., and Mufson, E. J. (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. N. Engl. J. Med. 332, 1118–1124.
Piccini, P., Brooks, D. J., Bjorklund, A., Gunn, R. N., Grasby, P. M., et al. (1999) Dopamine release from nigral transplants visualized in vivo in a Parkinson’s patient. Nat. Neurosci. 2, 1137–1140.
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med. 344 (10), 710–719.
Brustle, O., Jones, K., Learish, R., Karram, K., Choudhary, K., et al. (1999) Embryonic stem cell-derived glial precursors: a source of myelinated transplants. Science 285, 754–756.
McDonald, J., Liu, X.-Z., Qu, Y., Liu, S., Mickey, S., et al. (1999) Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5, 1410–1412.
Hurlbert, M. S., Gianani, R. I., Hutt, C., Freed, C. R., and Kaddis, F. G. (1999) Neural transplantation of hNT neurons for Huntington’s disease. Cell Transplant. 8 (1), 143–151.
Nishino, H. and Borlongan, C. V. (2000) Restoration of function by neural transplantation in the ischemic brain. Prog. Brain Res. 127, 461–476.
Bjorklund, A. and Lindvall, O. (2000) Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3 (6), 537–544.
Azizi, S. A. (2000) Exploiting nonneural cells to rebuild the nervous system: from bone marrow to brain. The Neuroscientist 6 (5), 353–361.
Turner, D. A. and Kearney, W. (1993) Scientific and ethical concerns in neural fetal tissue transplants. Neurosurgery 33, 1031–1037.
Rosenstein, J. M. (1995) Why do neural transplants survive? An examination of some metabolic pathophysiological considerations in neural transplantation. Exp. Neurol. 133, 1–6.
Snyder, E. (1997) The use of non-neural cells for gene delivery. Neurobiol. Dis. 4, 69–102.
Bencsics, C., Wachtel, S. R., Milstien, S., Hatakeyama, K., Becker, J. B., et al. (1996) Double transduction with GTP cyclohydrolase and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts.. 1. Neurosci. 16, 4449–4456.
Horellou, R, Brundin, R, Kalen, R, Mallet, J., and Bjorklund, A. (1990) In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5, 393–402.
Ljungberg, C. M., Stern, G., and Wilkin, G. R. (1999) Survival of genetically engineered, adult derived rat astrocytes grafted into the 6-hydroxy dopamine lesioned adult rat striatum. Brain Res. 816 (1), 29–37.
Takayama, H., Ray, J., Raymon, H. K., Baird, A., Hogg, J., et al. (1995) Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson’s disease. Nat. Med. 1, 53–58.
Lucidi-Phillipi, C. A., Gage, F. H., Shults, C. W., Jones, K. R., Reichardt, L. F., et al. (1995) Brain-derived neurotrophic factor-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain. J. Comp. Neurol. 354, 361–376.
Choi-Lundberg, D., Lin, Q., Chang, Y., Chiang, Y., Hay, C., et al. (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275, 838–841.
Choi-Lundberg, D. L., et al. (1998) Behavioral and cellular protection of rat dopaminergic neurons elicited by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp. Neurol. 154, 261–275.
Connor, B., et al. (1999) Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat. Gene Ther. 6, 1936–1951.
Connor, B., Kozlowski, D. A., Unnerstall, J. R., Elsworth, J. D., Tillerson, J. L., Schallert, T., et al. (2001) Glial cell line-derived neurotrophic factor (gdnf) gene delivery protects dopaminergic terminals from degeneration. Exp. Neurol. 169, 83–95.
Kawaja, M. and Gage, F. (1992) Morphological and neurochemical features of cultured primary skin fibroblasts of Fischer 344 rats following striatal implantation. J. Comp. Neurol. 317, 102–116.
Azizi, S. A., Stokes, D., Augelli, B. J., DiGirolamo, C., and Prockop, D. J. (1998) Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats—similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA 95, 3908–3913.
Prockop, D. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71–74.
Cohnheim, J. (1867) Arch. Pathol. Anat. Physiol. Clin. Med. 40, 1.
Friedenstein, A. J., Gorskaja, U., and Kulaagina, N. N. (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4, 267–274.
Pittenger, M., Mackay, A., Beck, S., Jaiswal, R., Douglas, R., et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147.
Periera, R. F., O’Hara, M. D., Laptev, A. V., Halford, K. W., Pollard, M. D., et al. (1998) Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA 95, 1142–1147.
Mezey, E., Chandross, K. J., Harta, G., Maki, R. A., and McKercher, S. R. (2000) Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290 (5497), 1779–1782.
Brazelton, T. R., Rossi, F. M., Keshet, G. I., and Blau, H. M. (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290 (5497), 1775–1779.
Ferrari, G., Cusella-DeAngelis, C., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G., et al. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528–1530.
Gussoni, E., Soneoka, Y., Strickland, C., Buzney, E., Khan, M., et al. (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390–394.
Galpern, W. R., Burns, L. H., Deacon, T. W., Dinsmore, J., and Isacson, O. (1996) Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson’s disease: functional recovery and graft morphology. Exp. Neurol. 140, 1–13.
Brook, F. A. and Gardner, R. L. (1997) The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA 94 (11), 5709–5712.
Laywell, E. D., Kukekov, V. G., and Steindler, D. A. Multipotent neurospheres can be derived from forebrain subependymal zone and spinal cord of adult mice after protracted postmortem intervals. Exp. Neurol. 156(2), 430–433.
Colter, D., Class, R., DiGirolamo, C., and Prockop, D. (2000) Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. USA 97, 2313–3218.
Ginns, E. I., Rehavi, M., Martin, B. M., Weller, M., O’Malley, K. L., et al. (1998) Expression of human tyrosine hydroxylase cDNA in invertebrate cells using a baculovirus vector. J. Biol. Chem. 263 (15), 7406–7410.
Miller, A. D. and Rosman, G. J. (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7(9), 980–982, 984–986, 989–990.
Hatakeyama, K., Inoue, Y., Harada, T., and Kagamiyama, H. (1991) Cloning and sequencing of cDNA encoding rat GTP cyclohydrolase I. The first enzyme of the tetrahydrobiopterin biosynthetic pathway. J. Biol. Chem. 266 (2), 765–769.
Schwarz, E. J., Guillermo, A. M., Prockop, D. J., and Azizi, S. A. (1999) Multipotential marrow stromal cells transduced to produce L-DOPA: engraft-ment in a rat model of Parkinson’s disease. Hum. Gene Ther. 10, 2539–2549.
Snyder, E. (1998) Neural stem-like cells: developmental lessons with therapeutic potential. The Neuroscientist 4, 408–425.
Snyder, E., Yoon, C., Flax, J., and Macklis, J. (1997) Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc. Natl. Acad. Sci. USA 94, 11,663–11, 668.
Yandava, B., Billinghurst, L., and Snyder, E. (1999) “Global” cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc. Natl. Acad. Sci. USA 96, 7029–7034.
Eriksson, P., Perfilieva, E., Bjork-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., et al. (1998) Neurogenesis in the adult human hippocampus. Nat. Med. 4, 1313.
Gould, E., Reeves, A., Graziano, S., and Gross, C. (1999) Neurogenesis in the neocortex of adult primates. Science 286, 548–552.
Nudo, R. J., Wise, B. M., SiFuentes, F., and Milliken, G. W. (1996) Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 272, 1791–1794.
Zhang, S.-C., Ge, B., and Duncan, I. (1999) Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc. Natl. Acad. Sci. USA 96, 4089–4094.
Nait-Oumesmar, B., Decker, L., Lachapelle, F., Avellana-Adalid, V., Bachelin, C., et al. (1999) Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur. J. Neurosci. 11, 4357–4366.
Snyder, E., Yandava, B., Pan, Z., Yoon, C., and Macklis, J. (1993) Immortalized postnatally-derived cerebellar progenitors can engraft and participate in development of multiple structures at multiple stages along mouse neuroaxis. Soc. Neurosci. Abstr. 19, 613.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Azizi, S.A., Schwarz, E.J., Prockop, D., Alexander, G., Mortati, K.A., Krynska, B. (2003). Utilization of Marrow Stromal Cells for Gene Transfer into the CNS. In: Zigova, T., Snyder, E.Y., Sanberg, P.R. (eds) Neural Stem Cells for Brain and Spinal Cord Repair. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-298-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-59259-298-2_15
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-298-8
Online ISBN: 978-1-59259-298-2
eBook Packages: Springer Book Archive